SLC5A2 and heart failure: In this study, no significant relationship was found between the use of SGLT2 inhibitors or GLP-1 receptor agonists and myocardial CT value (data not shown), though these medications have been reported to improve cardiac functions in human diabetic hearts [34] and in a mouse model of heart failure with preserved ejection fraction [35].